News & Events
-
Congressional Testimony 2010
Testimony of FDA officials before House and Senate Committees and Subcommittees.
-
September 2010
- 09/30/2010
Johnson and Johnson’s Recall of Children’s Tylenol and Other Children’s Medicines
Joshua M. Sharfstein, M.D., before the House Committee on Oversight and Government Reform - 09/22/2010
The Outbreak of Salmonella in Eggs Joshua M. Sharfstein, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
-
-
August 2010
- 08/19/2010
The BP Oil Spill: Accounting for the Spilled Oil and Ensuring the Safety of Seafood from the Gulf
Donald W. Kraemer, before the House Committee on Energy and Commerce, Subcommitee on Energy and Environment
-
-
July 2010
- 07/22/2010
Direct-to-Consumer Genetic Testing and the Consequences to the Public Jeffrey Shuren, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 07/21/2010
Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Health, Education, Labor and Pensions - 07/14/2010
Antibiotic Resistance and the Use of Antibiotics in Animal Agriculture Joshua M. Sharfstein, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
-
-
June 2010
- 06/23/2010
FDA's Efforts on Rare and Neglected Diseases
Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 06/16/2010
HHS Actions to Identify and Address Health Effects of the BP Oil Spill
Michael R. Taylor, J.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 06/15/2010
Evaluating the Health Impacts of the Gulf of Mexico Oil Spill Michael R. Taylor, J.D., before the Senate Committee on Health, Education, Labor and Pensions - 06/09/2010
Promoting the Development of Antibiotics and Ensuring Judicious Use in Humans Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
-
-
May 2010
- 05/27/2010
Johnson and Johnson's Recall of Children's Tylenol and Other Children's Medicines Joshua M. Sharfstein, M.D., before the House Committee on Oversight and Government Reform - 05/26/2010
Oversight of Dietary Supplements
Joshua M. Sharfstein, M.D., before the Senate Special Committee on Aging - 05/06/2010
The Role and Performance of FDA in Ensuring Food Safety
Michael R. Taylor, before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
-
-
April 2010
- 04/13/2010
Regulation of Pseudoephedrine Charles J. Ganley, M.D., before the Senate Caucus on International Narcotics Control
-
-
March 2010
- 03/10/2010
Drug Safety: An Update from FDA
Joshua M. Sharfstein, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 03/10/2010
President's Fiscal Year 2011 Budget Request for the FDA Margaret A. Hamburg, M.D., before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 03/09/2010
The President's Fiscal Year 2011 Budget Request for FDA Margaret A. Hamburg, M.D., before the Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
-
-
-